We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Achieving and maintaining ISO 17025:2017 Accreditation with LIMS support

Webinar

In today’s ever-changing and fast-paced business environment, having an accreditation is critical to your business. We also understand that becoming accredited can be a time consuming and onerous process and failing on accreditations can be unfavourable to your business.

Read more

How To Prevent Cell Culture Contamination

Infographic

Cells in culture are vulnerable to contaminants derived from a large range of potential sources. Download this infographic to arm yourself with knowledge about different types of contaminants, and find out how to avoid contamination of your cultures.

Read more

European Medicines Agency Approves Olaparib for Women With BRCA-mutant Breast Cancer

News

The targeted cancer drug olaparib has been approved by the European Medicines Agency (EMA) for women and men with advanced breast cancer who have inherited BRCA gene mutations.

Read more
 
Insights on Marijuana and Opioid Use in People With Cancer
News

A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time.

Read more

Pursuing Hair-restoration Therapy – For Your Inner Ear
News

An NIH grant has been awarded to a group studying "crista" – inner-ear vestibular structures that are relatively under-studied, but are crucial for balance. The research group hopes that

Read more

Triple-negative Breast Cancers Can Adopt Reversible State That is Resistant to Chemotherapy
News

Researchers have discovered that triple-negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells.

Read more

 
 
 
 
The Evolving Field of Cancer Biomarkers
Article

Given the complexity of cancer, it’s arguably unlikely that single molecules will work as clinically meaningful biomarkers for cancer. Today, biomarker discovery involves detecting patterns – characteristics or phenotypes that can be measured and monitored throughout a patient’s journey. Here, we look at two approaches being explored in this evolving field.

Read more

Sensitivity vs Specificity
Article

When developing diagnostic tests or evaluating results, it is important to understand how reliable those tests and therefore the results you are obtaining are. By using samples of known disease status, values such as sensitivity and specificity can be calculated that allow you to evaluate just that.

Read more

A Further Dimension to Drug Discovery: Combining 3D Culture With iPSCs
Article

Running in parallel with advances in 3D cell culture is the growing use of human cells derived from induced pluripotent stem cells. Researchers are interested in testing drugs in the most physiologically relevant models possible, so it was only a matter of time before these two approaches converged – providing optimized systems for disease modeling and drug toxicity testing.

Read more

Preclinical Modeling of Tumor Metastasis and Resistance: Current Challenges and New Approaches
Article

To improve cancer survival rates, pharma and biotech researchers must develop safe and effective therapies to treat not only primary tumors, but also metastatic growths and tumors that have acquired resistance.

Read more

The Power of Proteogenomics in Precision Medicine
Article

Part of the "systems biology" trend, proteogenomics is expanding at an accelerating rate. In this article, we look at the approaches adopted in proteogenomics and explore how proteogenomics is changing the dynamics of precision medicine in oncology.

Read more

How Drug–Diagnostic Co-development is Shaping Discovery Research and Pharmacotherapy
Article

This article reviews the importance and requirements for developing successful drug–diagnostic co-development models. It also highlights current challenges and ongoing efforts to address these issues, bringing us closer towards a more promising future for pharmacotherapy and patient care.

Read more